NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 922 filers reported holding NOVARTIS A G in Q2 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $84,795,000 | -5.0% | 882,000 | -15.2% | 8.09% | -3.1% |
Q4 2018 | $89,297,000 | +18.8% | 1,040,632 | +19.2% | 8.35% | +57.2% |
Q3 2018 | $75,188,000 | +93.0% | 872,701 | +69.8% | 5.31% | +102.1% |
Q2 2018 | $38,957,000 | +36.8% | 513,901 | +54.9% | 2.63% | +46.1% |
Q3 2017 | $28,483,000 | -37.9% | 331,775 | -39.6% | 1.80% | -34.8% |
Q2 2017 | $45,845,000 | – | 549,240 | – | 2.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |